{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "d3d2f1a8",
   "metadata": {},
   "source": [
    "Sepsis pathways:\n",
    "## 1. Inflammatory and Immune Pathways\n",
    "\n",
    "Cytokine Storm: Overproduction of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) leads to systemic inflammation.**TNF, IL1A, IL1B, IL6, IL8 (CXCL8), IL12A, IL12B, IFNG, TREM-1, TYROBP, LBP, HMGB1, ELANENeutrophil Extracellular Traps (NETs), CXCL8**\n",
    "\n",
    "Anti-inflammatory cytokines (e.g., IL-10, TGF-β) are also upregulated but may result in immunosuppression in later stages of sepsis.**IL10, TGFB1, IL1RN (IL-1 receptor antagonist), SOCS1, SOCS3**\n",
    "\n",
    "\n",
    "Toll-like Receptor (TLR) Signaling:TLRs recognize pathogen-associated molecular patterns (PAMPs) and activate immune responses.Dysregulated TLR signaling exacerbates inflammation and tissue damage.\n",
    "**TLR1, TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, MYD88, TICAM1 (TRIF), IRAK1, IRAK4, TRAF6, TIRAP, LBP**\n",
    "\n",
    "Inflammasome Components: **CASP1 (Caspase-1), GSDMD, PYCARD (ASC), AIM2**\n",
    "\n",
    "NOD-like Receptors:  **NLRP3, NLRC4, NLRP1, NOD1, NOD2, RIPK2**\n",
    "\n",
    "Complement Pathway Activation:Excessive complement activation contributes to inflammation, vascular permeability, and tissue injury.\n",
    "**C3, C3aR1, C5, C5AR1 (C5a receptor), CFB, CFD, CFH, C1QA, C1QB, C1QC**\n",
    "\n",
    "## 2.Acute Phase Response Pathway\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "The acute phase response is triggered by inflammatory cytokines such as IL-6, TNF-α, and IL-1β during infection or tissue injury.\n",
    "\n",
    "It involves the rapid production of acute-phase proteins like C-reactive protein (CRP), serum amyloid A (SAA), and fibrinogen by the liver.\n",
    "\n",
    "These proteins amplify inflammation, modulate the immune response, and facilitate pathogen clearance.\n",
    "\n",
    "Molecular Perspective:Key Genes:\n",
    "\n",
    "Acute Phase Proteins: **CRP, SAA1, HP (Haptoglobin), FGA, FGB, FGG (Fibrinogen chains), LBP**\n",
    "\n",
    "Cytokines Triggering the Acute Phase Response: **IL6, IL1B, TNF**\n",
    "\n",
    "Liver Detoxification Genes (Supporting Role): **CYP3A4, CYP2C9, CYP1A2**\n",
    "\n",
    "## 3. Coagulation Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Disseminated Intravascular Coagulation (DIC):Excessive clot formation depletes clotting factors, leading to microvascular thrombosis and bleeding.\n",
    "\n",
    "Tissue Factor (TF) Pathway Activation:Overexpression of TF leads to thrombin generation, fibrin deposition, and clot formation.\n",
    "\n",
    "Protein C Pathway Dysfunction:Impaired Protein C activation leads to loss of anticoagulant and anti-inflammatory effects.\n",
    "\n",
    "Fibrinolytic Impairment:Increased PAI-1 expression inhibits plasminogen activation, reducing clot breakdown.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Coagulation factors: **F2 (Prothrombin), F3 (Tissue Factor), F5, F7, F8, F9, F10, F11, ELANE , CXCL8**\n",
    "\n",
    "Anticoagulation pathway: **PROC (Protein C), PROS1 (Protein S), SERPINA5 (Protein C Inhibitor), THBD (Thrombomodulin)**\n",
    "\n",
    "Fibrinolytic pathway: **PLG (Plasminogen), PLAU (Plasminogen Activator), SERPINE1 (PAI-1), PLAUR**\n",
    "\n",
    "## 4. Vascular and Endothelial Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Endothelial Dysfunction:Endothelial cells lose integrity, causing vascular leakage and tissue edema.\n",
    "\n",
    "Microvascular Thrombosis:Microvascular clots impair blood flow, leading to organ ischemia.\n",
    "\n",
    "Vasodilation and Hypotension:Excess nitric oxide (NO) causes vasodilation, leading to septic shock.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Endothelial dysfunction: **SELE, ICAM1, VCAM1, PECAM1, VEGFA, TREM1, HMGB1, ELANE, CXCL8** \n",
    "\n",
    "Vascular barrier proteins: **CLDN5, OCLN, MMP9, MMP2**\n",
    "\n",
    "Nitric oxide regulation: **NOS2 (iNOS), NOS3 (eNOS), ARG1**\n",
    "\n",
    "Angiopoietin-Tie2 signaling: **ANGPT1, ANGPT2, TEK (Tie2)**\n",
    "\n",
    "## 5. Metabolic Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Hypermetabolism:Increased energy demand causes hyperglycemia and lipolysis.\n",
    "\n",
    "Mitochondrial Dysfunction:Impaired ATP production leads to energy deficits.\n",
    "\n",
    "Lactic Acidosis:Hypoperfusion and anaerobic glycolysis cause lactate buildup.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Glucose metabolism: **GCK, HK2, SLC2A4, PDK1, SLC2A4 (GLUT4), INS (Insulin), INSR (Insulin Receptor)**\n",
    "\n",
    "Mitochondrial dysfunction: **MT-ND1, MT-ND5, ATP5F1A, SDHB**\n",
    "\n",
    "Lactate metabolism:**LDHA, LDHB,  PDK1, PDK4**\n",
    "\n",
    "Lipid Metabolism:**CPT1A, PPARG, SREBF1 (SREBP1), FABP4 (Fatty Acid Binding Protein)**\n",
    "\n",
    "\n",
    "## 6. Oxidative Stress Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Reactive Oxygen Species (ROS) Overproduction:ROS damage lipids, proteins, and DNA, leading to cell injury.\n",
    "\n",
    "Antioxidant Depletion:Insufficient antioxidant defenses exacerbate oxidative damage.\n",
    "\n",
    "Molecular Perspective:Key Genes:\n",
    "\n",
    "ROS generation: **NOX1, NOX2 (CYBB), NOX4, SOD1, SOD2, TREM1, ELANE**\n",
    "\n",
    "Antioxidant defense: **GPX1, GPX4, CAT, PRDX1**\n",
    "\n",
    "## 7. Apoptosis and Cell Death Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Lymphocyte Apoptosis:Immune cell death weakens host defense.\n",
    "\n",
    "Endothelial Cell Death:Apoptosis and pyroptosis disrupt vascular integrity.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Caspase family: **CASP3,CASP6, CASP7, CASP8, CASP9**\n",
    "\n",
    "Pro-apoptotic genes: **BAX, BAK1**\n",
    "\n",
    "Anti-apoptotic genes: **BCL2,BCL2L1 (Bcl-xL), MCL1**\n",
    "\n",
    "Pyroptosis regulators: **NLRP3, CASP1, GSDMD, PYCARD, AIM2, HMGB1**\n",
    "\n",
    "## 8. Neuroendocrine Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation:Abnormal cortisol production affects immune and metabolic responses.\n",
    "\n",
    "Sympathetic Nervous System Activation:Excess catecholamines drive hypermetabolism and cardiovascular stress.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "HPA axis: **CRH, POMC, NR3C1, CALCA**\n",
    "\n",
    "Sympathetic nervous system: **ADRB1, ADRB2, TH**\n",
    "\n",
    "## 9. Autophagy Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Autophagy Impairment:Failure to clear damaged organelles and pathogens exacerbates cell dysfunction.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Core autophagy machinery: **ATG5, ATG7, BECN1, MAP1LC3B, SQSTM1, ULK1, SQSTM1 (p62)**\n",
    "\n",
    "\n",
    "## 10. Organ-Specific Pathways\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Acute Kidney Injury (AKI):Hypoperfusion, inflammation, and tubular damage impair renal function.\n",
    "\n",
    "Sepsis-Associated Encephalopathy (SAE):Neuroinflammation and blood-brain barrier disruption cause cognitive dysfunction.\n",
    "\n",
    "Liver Dysfunction:Reduced detoxification and bile production contribute to metabolic dysregulation.\n",
    "\n",
    "Cardiac Dysfunction:Myocardial depression and impaired contractility lead to shock.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "### Kidney injury:\n",
    "\n",
    "Acute Kidney Injury (AKI):**LCN2 (NGAL), HAVCR1 (KIM-1), SOD1, UMOD (Uromodulin)**\n",
    "\n",
    "RAAS Dysregulation: **AGT, REN, ACE, ACE2, AGTR1 (Angiotensin Receptor 1)**\n",
    "            \n",
    "### Brain pathways: \n",
    "\n",
    "Blood-Brain Barrier Integrity: **CLDN5, OCLN, MMP9, MMP2**\n",
    "\n",
    "Neuroinflammation: **GFAP (Glial Fibrillary Acidic Protein), TNF, IL1B, IL6**\n",
    "\n",
    "Neurotransmitter Regulation: **SLC6A3 (Dopamine Transporter), SLC6A4 (Serotonin Transporter)**\n",
    "\n",
    "### Liver dysfunction:\n",
    "\n",
    "Acute Phase Response:**CRP, SAA1, HP, FGA (Fibrinogen Alpha Chain), FGB, FGG**\n",
    "\n",
    "Detoxification: **CYP3A4, CYP2C9, CYP1A2**\n",
    "\n",
    "Cardiac dysfunction: **TNF, NOS3, MYH6,  MYH7, ACTC1 (Cardiac Actin)**\n",
    "\n",
    "## 11. Epigenetic and Transcriptomic Regulation\n",
    "\n",
    "Pathophysiological Perspective:\n",
    "\n",
    "Epigenetic Changes:Histone modifications and DNA methylation regulate inflammation and immune responses.\n",
    "\n",
    "Transcriptomic Dysregulation:Sepsis alters gene expression patterns, promoting maladaptive responses.\n",
    "\n",
    "Molecular Perspective:\n",
    "Key Genes:\n",
    "\n",
    "Epigenetic regulators: **HDAC1, DNMT1**\n",
    "\n",
    "Inflammation transcription factors:**NFKB1, STAT3, HIF1A**\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
